| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.5M | +314.0% | +170.6% |
| Cost of Revenue | $1.4M | +1102.6% | +253.5% |
| Gross Profit | $1.1M | +123.0% | +107.1% |
| R&D Expense | $2.0M | +1.8% | +61.6% |
| SG&A Expense | $11.1M | +181.3% | +384.3% |
| Operating Income | -$14.8M | -33.1% | -251.3% |
| Pre-tax Income | -$13.4M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $32.2M | +60.6% | +6201.0% |
| Accounts Receivable | $2.1M | +519.8% | +243.4% |
| Inventory | $1.4M | -42.4% | -47.5% |
| Current Assets | $36.7M | +51.5% | +262.0% |
| Total Assets | $47.9M | +35.2% | +63.7% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$30.4M | — | — |
| Capital Expenditures | $126K | — | — |
| Investing Cash Flow | -$126K | — | — |
| Financing Cash Flow | $58.6M | — | — |
| Free Cash Flow | -$30.5M | — | — |
| +35.5% |
| -203.2% |
| Income Tax | $1K | -88.9% | — |
| Net Income | -$13.4M | +35.5% | -203.2% |
| EPS (Basic) | -$0.61 | +79.2% | -369.2% |
| EPS (Diluted) | -$0.61 | +79.2% | -369.2% |
| $35.6M |
| +62.9% |
| +61.4% |
| Long-term Debt | $65K | +0.0% | +0.0% |
| Total Liabilities | $35.7M | +61.8% | +59.4% |
| Stockholders' Equity | $10.5M | -15.7% | +52.3% |